CMS unveils IRA prices for Ozempic, Wegovy and other drugs from second roundnews2025-11-25T23:09:56+00:00November 25th, 2025|Endpoints News|
Madrigal CEO welcomes MASH competition from Novo as demand climbs higher for Rezdiffranews2025-11-04T20:25:52+00:00November 4th, 2025|Endpoints News|
Merck CEO touts Winrevair launch, says he’s looking for deals ‘with urgency’news2025-10-30T18:49:30+00:00October 30th, 2025|Endpoints News|
Pfizer, Novartis, BMS, Lilly and others targeted in FDA’s TV ad crackdownnews2025-09-16T19:27:05+00:00September 16th, 2025|Endpoints News|
Trump directs more FDA enforcement of pharma adsnews2025-09-09T22:57:25+00:00September 9th, 2025|Endpoints News|
Gilead says it ‘hit the ground running’ on its long-acting HIV shot launchnews2025-08-08T01:57:40+00:00August 8th, 2025|Endpoints News|
Eli Lilly makes all Zepbound doses available in single-dose vials news2025-06-16T19:04:47+00:00June 16th, 2025|Endpoints News|
HHS says it may revisit policy for anti-obesity drugsnews2025-04-07T20:08:01+00:00April 7th, 2025|Endpoints News|
FDA cuts hit drug ad review office, in seeming contradiction with Kennedy’s goalsnews2025-04-01T19:00:29+00:00April 1st, 2025|Endpoints News|
J&J touts new survival data for lung cancer combonews2025-03-26T16:01:33+00:00March 26th, 2025|Endpoints News|
